|
|
|
- CAS号:
- 1330782-76-7
- 英文名:
- TAK-931
- 英文别名:
- TAK-931;SIMUROSERTIB;TAK-931，Simurosertib;Simurosertib (TAK-931);(S)-6-(3-methyl-1H-pyrazol-4-yl)-2-(quinuclidin-2-yl)thieno[3,2-d]pyrimidin-4(3H)-one;(S)-6-(3-Methyl-1H-pyrazol-4-yl)-2-(quinuclidin-2-yl)thieno[3,2-d]pyrimidin-4(1H)-one;Thieno[3,2-d]pyrimidin-4(3H)-one, 2-(2S)-1-azabicyclo[2.2.2]oct-2-yl-6-(3-methyl-1H-pyrazol-4-yl)-;2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)-1H,4H-thieno[3,2-d]pyrimidin-4-one;2-[(2S)-1-azabicyclo[2.2.2]octan-2-yl]-6-(5-methyl-1~{H}-pyrazol-4-yl)-3~{H}-thieno[3,2-d]pyrimidin-4-one;Inhibitor,anti-cancer,Cyclin dependent kinase,ATP-competitive,CDK,TAK931,Simurosertib,cycle,cell,orally,inhibit,division,TAK 931
- 中文名:
- TAK 931
- 中文别名:
- 化合物SIMUROSERTIB;(S)-6-(3-甲基-1H-吡唑-4-基)-2-(奎宁环-2-基)噻吩并[3,2-D]嘧啶-4(1H)-酮
- CBNumber:
- CB13364621
- 分子式:
- C17H19N5OS
- 分子量:
- 341.43
- MOL File:
- 1330782-76-7.mol
|
|
|